Loading...
Paroxysmal supraventricular tachycardia (PSVT), a common arrhythmia in young, otherwise healthy people, is not life-threatening in the absence of pre-excitation. Caused most often by atrioventricular (AV) nodal re-entrant tachycardia or by orthodromic AV re-entrant tachycardia involving an accessory pathway, PSVT may be treated with long-term prophylactic pharmacotherapy or catheter ablation. These investigators from Italy and Germany assessed an alternative therapy.
Subjects were 33 patients who had experienced infrequent (≤5/year), well-tolerated, long-lasting episodes of PSVT, inducible during electrophysiology testing. Five minutes after PSVT induction, subjects received 1 of 3 single-dose, oral regimens -- flecainide (3 mg/kg); diltiaze…